Contemporary accuracy of death certificates for coding prostate

A Risk Prediction Model for Mortality Among Smokers

Short Communication in 2016

Time-to-event Outcomes in Men with Nonmetastatic Castrate

Faculty Directory › UConn Health

Contemporary accuracy of death certificates for coding prostate

Genetically adjusted PSA levels for prostate cancer screening

Cutaneous melanoma, prostate-specific antigen testing and the

Comparison of Minimally Invasive Tissue Sampling With Conventional Autopsy to Detect Pulmonary Pathology Among Respiratory Deaths in a Resource-Limited Setting. - Document - Gale OneFile: Health and Medicine

CAP trial design. *Further n = 1451 excluded due to prostate cancer

Full article: New Insights into the Epidemiology of Prostate Cancer in Ontario

Author Search Results

Dr. Anthony L. Zietman, MD, Boston, MA, Radiation Oncologist

Biomedicines, Free Full-Text